• USA Home
  • 176905 - Anthrax Protective Antigen, Bacillus anthracis, Recombinant, B. anthracis - Calbiochem

EMAIL THIS PAGE TO A FRIEND
176905 Millipore

Anthrax Protective Antigen, Bacillus anthracis, Recombinant, B. anthracis - Calbiochem

Anthrax Protective Antigen, Bacillus anthracis, Recombinant, is the protective antigen that mediates the entry of anthrax lethal factor and edema factor into the target cell.

Purchase

Properties

Quality Level   100
form   lyophilized
mfr. no.   Calbiochem®
storage condition   OK to freeze
storage conditions   +2C to +8C
shipped in   ambient

Description

General description

Recombinant, Bacillus anthracis anthrax protective antigen expressed in a special strain of B. anthracis. One of three protein components of anthrax toxin produced by the pathogenic bacterium, Bacillus anthracis. Central moiety that mediates entry of lethal factor (LF) and edema factor (EF) into the target cell. PA83 binds to the cell surface via a type I membrane receptor with a von Willebrand factor A domain, known as anthrax toxin receptor. PA83 is proteolytically activated in vivo by a furin-like protease to produce a 63 kDa protein (PA63). PA63 self-associates to form a heptameric, cation-selective, voltage-gated, membrane channel that subsequently binds to LF and/or EF. Cleavage of the 20 kDa fragment from PA83 is necessary for binding of protective antigen to LF and EF.

Recombinant, Bacillus anthracis anthrax protective antigen expressed in a specialized strain of B. anthracis. One of the three protein components of Anthrax toxin, protective antigen (PA) is the central moiety that mediates the entry of lethal factor and edema factor into the target cell. PA binds to the cell surface via a type I membrane protein with a von Willebrand factor A domain called anthrax toxin receptor. After proteolytic activation to a 63 kDa fragment, PA self-associates to form a heptameric cation-selective, voltage-gated membrane channel.

Packaging

100 μg in Plastic ampoule

Biochem/physiol Actions

Cell permeable: no

Primary Target
Type I membrane protein with a von Willebrand factor A domain called anthrax toxin receptor

Product does not compete with ATP.

Reversible: no

Packaging

yes

Warning

Toxicity: Standard Handling (A)

Physical form

Lyophilized from 50 mM NaCl, 5 mM HEPES, pH 7.5.

Reconstitution

Following reconstitution aliquot and freeze (-20°C). Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 6 months at -20°C.

Reconstitute in 100 µl sterile, distilled H₂O to yield a final concentration of 1 mg/ml.

Analysis Note

Single major band by SDS-PAGE. Several smaller minor components are apparent that may represent cleavage fragments of the PA.

Other Notes

Mogridge, J., et al. 2002. Biochemistry41, 1079.
Nassi, S., et al. 2002. Biochemistry41, 1445.
Ahuja, N., et al. 2001. Biochem. Biophys. Res. Commun.286, 6.
Bradley, K.A., et al. 2001. Nature414, 225.
Brossier, F., and Mock, M. 2001. Toxicon39, 1747.

Safety & Documentation

Safety Information

Safety Information for this product is unavailable at this time.
Protocols & Articles
Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?